Clinical Trial: Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Immunogenicity Profiles of Single Doses of HCXT-2001 Tablets (A) in Healthy Adult Participants, and the Effect of Food on the Pharmacokinetics of HCXT-2001 Tablets (A) (China)

China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Immunogenicity Profiles of Single Doses of HCXT-2001 Tablets (A) in Healthy Adult Participants, and the Effect of Food on the Pharmacokinetics of HCXT-2001 Tablets (A)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132124

Registration Time: 2026/09/09

Type: Interventional study

Primary Sponsor: The Second Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335935

Published by HT Digital Content Services with permission from Health Daily ...